cbdMD Inc (YCBD)

Currency in USD
1.245
-0.035(-2.73%)
Real-time Data·
YCBD is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
1.2201.300
52 wk Range
0.5906.538
Key Statistics
Prev. Close
1.28
Open
1.24
Day's Range
1.22-1.3
52 wk Range
0.59-6.538
Volume
133.96K
Average Volume (3m)
3.51M
1-Year Change
-63.3%
Book Value / Share
0.69
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell
YCBD Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
2.000
Upside
+60.64%
Members' Sentiments
Bearish
Bullish
ProTips
Stock generally trades with high price volatility

cbdMD Inc News & Analysis

Show more

cbdMD Inc Company Profile

cbdMD, Inc. produces and distributes various cannabidiol (CBD) products in the United States. The company owns and operates consumer hemp-based CBD brands, such as cbdMD, Paw CBD, hempMD, and cbdMD Botanicals. Its cbdMD brand products include CDB tinctures, gummies, topicals, capsules, drink mixes, ready to drink cans, and sleep, focus, and calming aids. It also provides veterinarian-formulated products, including tinctures, chews, and topicals under the Paw CBD brand name; nootropic mushroom line under the ATRx brand; and hemp derived solutions under the hempMD brand. It distributes its products through its e-commerce website, third-party e-commerce sites, select distributors and marketing partners, wholesalers, and various brick and mortar retailers. The company was formerly known as Level Brands, Inc. and changed its name to cbdMD, Inc. in May 2019. cbdMD, Inc. is headquartered in Charlotte, North Carolina.

Employees
42

cbdMD Inc Earnings Call Summary for Q3/2025

  • cbdMD reported Q3 2025 EPS of -$0.21, missing expectations with revenue of $4.61M, a 15.72% miss vs. forecast of $5.47M
  • Stock price fell 16.9% post-earnings, with further declines in aftermarket trading to $0.627
  • Net loss of $895,000 reported, compared to $459,000 income in prior year; YTD net loss reduced from $3.5M to $1.3M
  • Company aims to drive DTC growth, expand wholesale, and maintain 60% gross margins despite regulatory challenges
  • CEO highlighted structural changes to reverse revenue decline, emphasizing benefits of regulatory compliance for prepared companies
Last Updated: 20/08/2025, 10:42
Read Full Transcript

Compare YCBD to Peers and Sector

Metrics to compare
YCBD
Peers
Sector
Relationship
P/E Ratio
−2.4x−9.9x−0.7x
PEG Ratio
−0.02−0.120.00
Price/Book
1.9x0.4x2.6x
Price / LTM Sales
0.6x4.7x3.4x
Upside (Analyst Target)
56.3%18.4%37.8%
Fair Value Upside
Unlock16.0%5.5%Unlock

Analyst Ratings

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 2.000
(+60.64% Upside)

Earnings

Latest Release
Aug 14, 2025
EPS / Forecast
-0.21 / --
Revenue / Forecast
4.61M / 5.47M
EPS Revisions
Last 90 days

YCBD Income Statement

People Also Watch

3.25
NUAI
+38.30%
28.37
CRML
+21.86%
1.827
DVLT
+7.49%
9.6450
ORBS
-4.32%
8.920
LAC
+5.81%

FAQ

What Stock Exchange Does cbdMD Trade On?

cbdMD is listed and trades on the New York Stock Exchange stock exchange.

What Is the Stock Symbol for cbdMD?

The stock symbol for cbdMD is "YCBD."

What Is the cbdMD Market Cap?

As of today, cbdMD market cap is 11.31M.

What Is cbdMD's Earnings Per Share (TTM)?

The cbdMD EPS (TTM) is -2.41.

From a Technical Analysis Perspective, Is YCBD a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Buy.

How Many Times Has cbdMD Stock Split?

cbdMD has split 2 times.

How Many Employees Does cbdMD Have?

cbdMD has 42 employees.

What is the current trading status of cbdMD (YCBD)?

As of 14 Oct 2025, cbdMD (YCBD) is trading at a price of 1.245, with a previous close of 1.28. The stock has fluctuated within a day range of 1.220 to 1.300, while its 52-week range spans from 0.590 to 6.538.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.